Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Rotarex<sup>®</sup>S combined with DCB seems safe and provides acceptable 12-month primary patency and TLR rates in femoropopliteal in-stent restenosis. Well-designed comparative or large registry studies are necessary to provide high quality and long-term data on this technique to provide firm conclusions on the efficacy of Rotarex<sup>®</sup>S and DCB in ISR in the femoropopliteal area.
Authors
- Jianming Guo (ORCID: https://orcid.org/0000-0002-4343-8622)
- Yongquan Gu (ORCID: https://orcid.org/0000-0002-2869-9736)
- Dikang Pan (ORCID: https://orcid.org/0000-0001-8603-353X)
- Wenzhuo Meng (ORCID: https://orcid.org/0009-0001-2159-7032)
- Sensen Wu (ORCID: https://orcid.org/0000-0001-8304-8998)
- Lianrui Guo (ORCID: https://orcid.org/0009-0005-5746-6500)
- Yachan Ning
- Hui Wang (ORCID: https://orcid.org/0000-0001-8478-9990)
Institutions
- Capital Medical University (CN)
Publication Details
- Journal
- Journal of Cardiothoracic Surgery
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1186/s13019-024-03164-1
- Citations
- 4
- Primary Topic
- Peripheral Artery Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 2.29
Funders
- National Key Research and Development Program of China